In addition, Bach2 overexpression inhibited the levels of IL‐9 and the proportions of Th9 cells, whereas IRF4 up‐regulation enhanced the levels of IRF4 and IL‐9 and the proportions of Th9 cells in the CD4+ T cells of SLE patients and healthy volunteers. This evidence concerns the gene CD4 and systemic lupus erythematosus.